BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...

Så ska USA satsa på life science

I president Obamas budgetförslag för år 2016 nämns bland annat en satsning mot spridningen av antibiotikaresistens och ett initiativ för individanpassad medicin.

En snyggare Biotechsweden.se

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.

Gates satsar på Crispr

Microsoft-grundaren finansierar genterapibolaget Editas Medicine.

Esteya får grönt ljus i USA

Elektas nya behandlingssystem för behandling av hudcancer får klartecken att lanseras på den amerikanska marknaden.

Satsar på modifierade antikroppar

Antikroppskonjugat är en av nästa generations antikroppstekniker. De kan användas för en målinriktad behandling, exempelvis vid cancer.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Happy exhibitors!

There were fewer vistors this year but most exhibitors are content.

Top modern lab to Sahlgrenska

The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.

Siemens och Raysearch gör slut

Medicinteknikbolagen Raysearch laboratories och Siemens Healthcare har beslutat att avsluta sitt samarbete.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Danisco first with green emulsifier

A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Medtech giant separates

Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

KI i open innovation-samarbete

Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.